Menon Biosensors, Inc.

16550 West Bernardo Drive
Bldg 5, Suite 525, CA 92127-1870 USA
Click for website

Research Sector Infectious Disease

Summary Description Molecular biochemistry company analyzing for rapid detection and diagnosis of biological pathogens.

Management Suresh Menon, PhD., Founder and President; Gregory P Hanson CMA, MBA, Acting CFO/Advisory Board Member; David Schlotterbeck, Chairman Advisory Board

Click here for Financial Data
Keywords: infectious disease, biological pathogens, diagnostics device, assays, nuclear magnetic resonance, NMR, molecular mirroring M(2) technology


Updated: Apr. 05, 2016


Microfluidics and M2 NMR platform technology (classified by the U.S. Government until 2012) provides superior sensitivity and specificity and minimizes sample preparation, providing best in class samp......view more

Products / Services

Portable biosensor and assays detect a variety of biological pathogens. The robust platform technology enables Menon to develop new assays for serious worldwide diseases in just 60 to 90 days, while ......view more

Technology / Differentiation

M(2) (Molecular Mirroring) nuclear magnetic resonance (NMR) technology has been validated through multiple studies with the U.S. government's Bio-defense Program. In these studies, in more than 3,000 ...view more

Market / Customers

Healthcare Diagnostics; Food and Water Safety Testing Healthcare/Food safety/livestock testing - Menon Biosensor provides accurate results in less than one hour from the time a sample is collected.......view more

Revenue / Funding

Funding to Date: $20 MM Financing Sought: $30 MM...view more


SAN DIEGO, January 9, 2014 Menon Biosensors, Inc. a molecular biochemistry company that provides DNA analysis for the diagnosis of biological pathogens, announced today that its M2 (Molecular Mirror...view more


Law Firm: DLA Piper, LLP Banker: Healthios Accounting Firm: Swenson Advisors LLP, Certified Public Accountants...view more